羟乙基淀粉中环氧乙烷残留量检查的方法探究
摘要
中分子羟乙基淀粉200/0.5是目前世界各国广泛应用于容量治疗和休克的血浆增量剂,由于结构和糖元接近,过敏性样反应发生率最低,近年评价较高,是一个副作用少、外科手术及危重病治疗中理想的血浆增量剂。在进行羟乙基化反应过程中使用了环氧乙烷。原料中有少量残留,故对环氧乙烷残留量以及羟乙基淀粉的质量控制进行探究。
出处
《内蒙古石油化工》
CAS
2008年第11期30-30,共1页
Inner Mongolia Petrochemical Industry
二级参考文献33
-
1张友松,李广芬.变性淀粉在纺织工业中的应用[J].淀粉与淀粉糖,1994(1):10-17. 被引量:3
-
2Treib J, Baron JF, Grauer MT, et al. An international view of hydroxyethyl starches[J]. Intensive Care Meal, 1999,25 (3) : 258 -268.
-
3Jungheinrich C, Sauermann W, Bepperling F, et al. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery: a randomised, double-blind study[J]. Drugs R D, 2004,5(1) : 1 - 9.
-
4Sander O, Reinhart K, Hellmann AM. Equivalence of hydroxyethyl starch HES 130/0.4 and HES 200/0.5 for perioperative volume replacement in major gynaecological surgery [J]. Acta Anaesthesiol Scand,2003,47(9) : 1151 - 1158.
-
5Treib J, Haass A, Pindur G, ct al. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions,and coagulation[J]. Transfusion, 1996,36(5) :450 - 455.
-
6Treib J, Haass A, Pindur G, et al. HES 200/0.5 is not HES 200/0.5 Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch(HES) on hemorheology, coagulation and elimination kinetics [J].Thromb Hoemost, 1995,74(6) : 1452 - 1456.
-
7Waitzinger J, Bepperling F, Pabst G. et al. Effect of a new hydroxyethyl starch(HES) specification(6% HES 130/0.4) on blood and plasma volumes after bleeding in 12 healthy male volunteers[Jj.Clin Drug Invest, 1999,17 ( 2 ) : 119 - 125.
-
8Waitzinger J, Bepperling F, Pabst G, et al. Pharmacokinetics and tolerability of a new hydroxyethyl starch ( HES ) specification ( 6%HES130/0.4) after single-dose infusion of 6% or 10% solution in heahhy volunteers[J]. Clin Drug Invest, 1998,16(2) : 151 - 160.
-
9Waitzinger J, Bepper]ing F, Pabst G, et al. Hydroxyethy] starch (HES) [ 130/0.41, a new HES specification : pharmaeokineties and safety after multiple infusions of 10% solution in healthy volunteers[J]. Orugs R O ,2003,4(3) : 149 - 157.
-
10Leuschner J, Opitz J, Winkler A, et al. Tissue storage of ^14 C-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats[J]. Drugs R D, 2003,4(6) :331 - 338.
共引文献30
-
1Seng Boravat,徐在品,赵梦婕,黄豪圣,路美兰,雷林,李思南,王瑶,明东东.羟乙基淀粉130/0.4联合肾上腺素对失血性休克犬心脏功能的影响[J].黑龙江畜牧兽医,2020(21):95-98.
-
2罗逸,刘菊蓉,郭兴蓬,陈蔚江.合成产物羟乙基淀粉主要质控指标研究[J].药物分析杂志,2004,24(3):296-298. 被引量:6
-
3李永红,蔡永红,曹凤芝,张普玉.化学改性淀粉的研究进展[J].化学研究,2004,15(4):71-74. 被引量:3
-
4薛新顺,罗发兴,黄强.淀粉基胶粘剂在建筑涂料中的应用[J].中国胶粘剂,2006,15(3):45-47. 被引量:1
-
5麻孝勇.淀粉在涂料中的应用[J].安徽化工,2007,33(1):24-26.
-
6赵学智,邵自强,王文俊.淀粉衍生物的研究及应用[J].广州化学,2007,32(1):56-61. 被引量:9
-
7王亚平,邹定全,常业恬.羟乙基淀粉130/0.4对兔内毒素性急性肺损伤的影响[J].临床麻醉学杂志,2007,23(5):412-414. 被引量:7
-
8陈玉皇,唐永林,王希臻.羟乙基淀粉130/0.4氯化钠注射液致荨麻疹[J].药物不良反应杂志,2007,9(4):290-290. 被引量:6
-
9杜连文,黄志萍,杨淮英,张书华.旋光法测定羟乙基淀粉200/0.5的含量[J].实用药物与临床,2009,12(1):35-35. 被引量:1
-
10杨淮英,杜连文,郑利伟.羟乙基淀粉200/0.5细菌内毒素检查[J].蛇志,2009,21(2):140-141.
-
1苏立强,史景江.羟乙基淀粉的裂解气相色谱研究[J].齐齐哈尔轻工业学院学报,1992,8(2):35-40.
-
2张光旭,胡张雁,尤燕青,方园.相转移催化合成羧甲基-羟乙基淀粉及工艺优化[J].中国粮油学报,2011,26(12):34-38. 被引量:3
-
3徐立宏,张本山,高大维.羟乙基淀粉的制备与应用[J].粮食与饲料工业,2001(11):41-43. 被引量:17
-
4苏爱华,陆光裕,卓仪荣.部分羟乙基化β-环糊精的制备[J].海峡药学,1999,11(2):6-7. 被引量:4
-
5杜连起.低DE值麦芽糊精的生产[J].淀粉与淀粉糖,2000(1):25-25. 被引量:2
-
6清源.块菌调味酱的工艺研究[J].中国调味品,2016,41(12):77-80. 被引量:5
-
7陈凤,杨成.酶催化合成羟乙基淀粉/ε-己内酯接枝共聚物[J].化学研究与应用,2009,21(10):1451-1452. 被引量:1
-
8程柱生.茶叶中是否有鞣酸[J].贵州茶叶,2012(3):8-10. 被引量:2
-
9袁秋萍.乳酸链球菌素在肉制品中的应用[J].食品工业科技,1998,19(4):27-28. 被引量:55
-
10郝爱友,张海光.高粘性羟乙基淀粉的制备及其性能[J].应用化学,2000,17(5):553-554. 被引量:1